Ferro Sanol



Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Obstructive Pulmonary Disease 10.9%
Cardiac Failure 8.7%
Infantile Spasms 8.7%
Pain 8.7%
Diabetes Mellitus Insulin-dependent 6.5%
Drug Use For Unknown Indication 6.5%
Thrombophilia 6.5%
Anaemia 4.3%
Bronchitis 4.3%
Dyslipidaemia 4.3%
Nausea 4.3%
Prophylaxis 4.3%
Sleep Disorder 4.3%
Thrombosis Prophylaxis 4.3%
Bronchopulmonary Dysplasia 2.2%
Dyspepsia 2.2%
Gastritis Prophylaxis 2.2%
Hypokalaemia 2.2%
Hypopituitarism 2.2%
Hypothyroidism 2.2%
Myalgia 12.5%
Neonatal Respiratory Distress Syndrome 12.5%
Oligohydramnios 12.5%
Rhabdomyolysis 12.5%
Stevens-johnson Syndrome 12.5%
Suicide Attempt 12.5%
Systolic Hypertension 12.5%
Vomiting 12.5%
Concomitant
Product Used For Unknown Indication 18.7%
Hypertension 12.7%
Breast Cancer 11.7%
Drug Use For Unknown Indication 8.5%
Rheumatoid Arthritis 6.7%
Pain 6.1%
Prophylaxis Against Gastrointestinal Ulcer 3.1%
Prophylactic Chemotherapy 3.0%
Prophylaxis 3.0%
Urinary Tract Infection 3.0%
Nausea 2.8%
Anaemia 2.7%
Iron Deficiency Anaemia 2.7%
Type 2 Diabetes Mellitus 2.6%
Atrial Fibrillation 2.4%
Restless Legs Syndrome 2.4%
Prostate Cancer 2.3%
Vomiting 2.1%
Bone Pain 1.7%
Crohn's Disease 1.7%
Prothrombin Time Prolonged 8.4%
Vomiting 7.4%
Clostridium Difficile Colitis 6.3%
Drug Effect Decreased 6.3%
Drug Exposure During Pregnancy 5.3%
Pulmonary Embolism 5.3%
Pyrexia 5.3%
Skin Necrosis 5.3%
Suicide Attempt 5.3%
Ureteral Stent Removal 5.3%
Drug Interaction 4.2%
Gastric Haemorrhage 4.2%
Neonatal Respiratory Distress Syndrome 4.2%
Thrombocytopenia 4.2%
Troponin Increased 4.2%
Tuberculosis 4.2%
Urosepsis 4.2%
Vitreous Haemorrhage 4.2%
Adrenal Neoplasm 3.2%
Electrocardiogram Qt Prolonged 3.2%
Interacting
Iron Deficiency 50.0%
Sinusitis 50.0%
Loss Of Consciousness 100.0%